Chimeric Stimuli-Responsive Liposomes as Nanocarriers for the Delivery of the Anti-Glioma Agent TRAM-34
Autor: | Jakub Kajdanek, Stefano Garofalo, Łucja Balcerzak, Katarzyna Milowska, Natassa Pippa, Maria Bryszewska, Evangelia Sereti, Maksim Ionov, Cristina Limatola, Stergios Pispas, Marta Kędzierska, Costas Demetzos, Varvara Chrysostomou, Konstantinos Dimas, Nikolaos Naziris |
---|---|
Přispěvatelé: | Laboratory of Microscopic Imaging and Specialized Biological Techniques, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Polymers Apoptosis 02 engineering and technology Drug Delivery Systems Tumor Cells Cultured Biology (General) Chimeric liposomes Drug delivery Functional Glioblastoma PH-responsive TRAM-34 Cell Proliferation Drug Carriers Glioma Humans Hydrogen-Ion Concentration Liposomes Nanoparticles Pyrazoles Spectroscopy pH-responsive Liposome Cultured Chemistry General Medicine 021001 nanoscience & nanotechnology Computer Science Applications Tumor Cells 0210 nano-technology Biocompatibility QH301-705.5 Catalysis Article Inorganic Chemistry 03 medical and health sciences In vivo medicine Physical and Theoretical Chemistry Molecular Biology QD1-999 chimeric liposomes Organic Chemistry glioblastoma medicine.disease In vitro functional 030104 developmental biology Nanotoxicology drug delivery Cancer research Nanocarriers |
Zdroj: | International Journal of Molecular Sciences, Vol 22, Iss 6271, p 6271 (2021) International Journal of Molecular Sciences Volume 22 Issue 12 |
ISSN: | 1661-6596 1422-0067 |
Popis: | Nanocarriers are delivery platforms of drugs, peptides, nucleic acids and other therapeutic molecules that are indicated for severe human diseases. Gliomas are the most frequent type of brain tumor, with glioblastoma being the most common and malignant type. The current state of glioma treatment requires innovative approaches that will lead to efficient and safe therapies. Advanced nanosystems and stimuli-responsive materials are available and well-studied technologies that may contribute to this effort. The present study deals with the development of functional chimeric nanocarriers composed of a phospholipid and a diblock copolymer, for the incorporation, delivery and pH-responsive release of the antiglioma agent TRAM-34 inside glioblastoma cells. Nanocarrier analysis included light scattering, protein incubation and electron microscopy, and fluorescence anisotropy and thermal analysis techniques were also applied. Biological assays were carried out in order to evaluate the nanocarrier nanotoxicity in vitro and in vivo, as well as to evaluate antiglioma activity. The nanosystems were able to successfully manifest functional properties under pH conditions, and their biocompatibility and cellular internalization were also evident. The chimeric nanoplatforms presented herein have shown promise for biomedical applications so far and should be further studied in terms of their ability to deliver TRAM-34 and other therapeutic molecules to glioblastoma cells. |
Databáze: | OpenAIRE |
Externí odkaz: |